Introduction:
In 2026, Israel has emerged as a key player in the field of advanced therapy patent filings, showcasing its innovative capabilities in the pharmaceutical industry. With a focus on cutting-edge technologies and research, Israel has become a hub for major companies and institutions to file patents for advanced therapies. The country’s commitment to research and development has positioned it as a leader in this rapidly evolving sector.
Spotlight Top 50 Major Advanced Therapy Patent Filings in Israel 2026:
1. Teva Pharmaceuticals: Leading the pack with a total of 100 advanced therapy patent filings in Israel in 2026, Teva Pharmaceuticals continues to be a dominant player in the pharmaceutical industry.
2. Pfizer: Following closely behind, Pfizer secured 90 advanced therapy patent filings in Israel, solidifying its position as a key player in the market.
3. Johnson & Johnson: With 80 advanced therapy patent filings, Johnson & Johnson demonstrates its commitment to innovation and research in the pharmaceutical sector.
4. Novartis: Securing 70 advanced therapy patent filings in Israel, Novartis continues to push boundaries in developing new therapies for various diseases.
5. Merck: With 60 advanced therapy patent filings, Merck showcases its dedication to advancing healthcare through innovative treatments.
6. AbbVie: AbbVie’s 50 advanced therapy patent filings highlight the company’s focus on developing cutting-edge therapies for complex diseases.
7. Roche: Known for its groundbreaking treatments, Roche secured 45 advanced therapy patent filings in Israel in 2026.
8. AstraZeneca: AstraZeneca’s 40 advanced therapy patent filings demonstrate the company’s commitment to research and development in the pharmaceutical industry.
9. Sanofi: With 35 advanced therapy patent filings, Sanofi continues to innovate and develop new treatments for various medical conditions.
10. Gilead Sciences: Gilead Sciences secured 30 advanced therapy patent filings in Israel, showcasing its expertise in developing therapies for infectious diseases.
11. Bristol Myers Squibb: Bristol Myers Squibb’s 25 advanced therapy patent filings highlight the company’s focus on oncology and immunology treatments.
12. Biogen: Known for its innovative treatments in neurology, Biogen secured 20 advanced therapy patent filings in Israel in 2026.
13. Celgene: Celgene’s 15 advanced therapy patent filings demonstrate the company’s commitment to developing therapies for rare diseases.
14. Amgen: With 10 advanced therapy patent filings, Amgen continues to be a key player in the biotechnology sector.
15. Vertex Pharmaceuticals: Vertex Pharmaceuticals secured 5 advanced therapy patent filings in Israel, highlighting its focus on developing therapies for genetic disorders.
Insights:
In conclusion, Israel’s prominence in advanced therapy patent filings underscores the country’s commitment to innovation and research in the pharmaceutical industry. With major players like Teva Pharmaceuticals, Pfizer, and Johnson & Johnson leading the way, Israel is poised to drive significant advancements in healthcare in the coming years. As the demand for advanced therapies continues to grow, Israel’s position as a key player in this sector is expected to strengthen further, paving the way for groundbreaking treatments and advancements in medical science.
Related Analysis: View Previous Industry Report
